A pharmaceuticals company has received fast-track designation from the U.S. Food and Drug Administration for the production of a drug that could possibly prevent malaria in adults.
A pharmaceuticals company has received fast-track designation from the U.S. Food and Drug Administration for the production of a drug that could possibly prevent malaria in adults.